NASDAQ:AMGN - Amgen News Headlines

Sign in or create an account to add this stock to your watchlist.
$191.76 -1.04 (-0.54 %)
(As of 07/19/2018 04:00 PM ET)
Previous Close$192.80
Today's Range$190.29 - $192.85
52-Week Range$163.31 - $201.23
Volume2.47 million shs
Average Volume4.02 million shs
Market Capitalization$128.32 billion
P/E Ratio15.24
Dividend Yield2.72%
Beta1.38

Headlines

Amgen (NASDAQ AMGN) News Headlines

Source:
DateHeadline
Amgen And Cedars-Sinai Partner For Improved Healthcare QualityAmgen And Cedars-Sinai Partner For Improved Healthcare Quality
finance.yahoo.com - July 19 at 4:55 PM
Amgen (AMGN) Scheduled to Post Earnings on ThursdayAmgen (AMGN) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - July 19 at 1:28 AM
Amgen, Inc. (AMGN) Expected to Post FY2019 Earnings of $14.69 Per ShareAmgen, Inc. (AMGN) Expected to Post FY2019 Earnings of $14.69 Per Share
www.americanbankingnews.com - July 18 at 7:42 AM
Leerink Swann Comments on Amgen, Inc.s Q2 2018 Earnings (AMGN)Leerink Swann Comments on Amgen, Inc.'s Q2 2018 Earnings (AMGN)
www.americanbankingnews.com - July 17 at 8:06 AM
Pacira Focused on Exparel Development Amid CompetitionPacira Focused on Exparel Development Amid Competition
finance.yahoo.com - July 17 at 8:02 AM
Insider Selling: Amgen, Inc. (AMGN) EVP Sells 1,525 Shares of StockInsider Selling: Amgen, Inc. (AMGN) EVP Sells 1,525 Shares of Stock
www.americanbankingnews.com - July 16 at 10:10 PM
Jefferies Financial Group Analysts Give Amgen (AMGN) a $200.00 Price TargetJefferies Financial Group Analysts Give Amgen (AMGN) a $200.00 Price Target
www.americanbankingnews.com - July 16 at 10:33 AM
Biotech Analysis Central Pharma News: Celgenes Protocol Change, Roches BLA For Herceptin, Amgens Resubmission For OsteoporosisBiotech Analysis Central Pharma News: Celgene's Protocol Change, Roche's BLA For Herceptin, Amgen's Resubmission For Osteoporosis
seekingalpha.com - July 16 at 8:52 AM
Better Buy: Biogen Inc. vs. AmgenBetter Buy: Biogen Inc. vs. Amgen
finance.yahoo.com - July 15 at 8:16 AM
Morgan Stanley Boosts Amgen (AMGN) Price Target to $210.00Morgan Stanley Boosts Amgen (AMGN) Price Target to $210.00
www.americanbankingnews.com - July 15 at 4:56 AM
Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY™ (romosozumab) To The US FDAAmgen And UCB Resubmit Biologics License Application (BLA) For EVENITY™ (romosozumab) To The US FDA
finance.yahoo.com - July 14 at 3:25 PM
Amgen, UCB Resubmit BLA For EVENITY To FDAAmgen, UCB Resubmit BLA For EVENITY To FDA
www.nasdaq.com - July 14 at 3:25 PM
Amgen resubmits U.S. marketing application for osteoporosis med EvenityAmgen resubmits U.S. marketing application for osteoporosis med Evenity
seekingalpha.com - July 14 at 3:25 PM
Amgen Resubmits BLA to FDA for Osteoporosis Candidate EvenityAmgen Resubmits BLA to FDA for Osteoporosis Candidate Evenity
www.zacks.com - July 14 at 3:25 PM
Is the Options Market Predicting a Spike in Amgen (AMGN) Stock?Is the Options Market Predicting a Spike in Amgen (AMGN) Stock?
finance.yahoo.com - July 14 at 3:25 PM
Benzingas Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices OfferingBenzinga's Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices Offering
finance.yahoo.com - July 14 at 3:25 PM
Better Buy: Amgen Inc. vs. Johnson & JohnsonBetter Buy: Amgen Inc. vs. Johnson & Johnson
finance.yahoo.com - July 14 at 3:25 PM
August 31st Options Now Available For Amgen (AMGN)August 31st Options Now Available For Amgen (AMGN)
www.nasdaq.com - July 12 at 4:56 PM
Amgen, Constellation Brands And Some ETFs: Fast Money Picks For July 11Amgen, Constellation Brands And Some ETFs: 'Fast Money' Picks For July 11
www.benzinga.com - July 11 at 8:03 AM
Biosimilars Market 2023 Exclusive Analysis – Pfizer, Teva Pharmaceuticals Industries Ltd., Sandoz International GmbH ...Biosimilars Market 2023 Exclusive Analysis – Pfizer, Teva Pharmaceuticals Industries Ltd., Sandoz International GmbH ...
www.marketwatch.com - July 11 at 8:03 AM
Amgen Reaches Analyst Target PriceAmgen Reaches Analyst Target Price
www.nasdaq.com - July 10 at 5:08 PM
Moving Average Crossover Alert: Amgen (AMGN)Moving Average Crossover Alert: Amgen (AMGN)
finance.yahoo.com - July 10 at 5:08 PM
Q3 2018 EPS Estimates for Amgen, Inc. (AMGN) Raised by Jefferies Financial GroupQ3 2018 EPS Estimates for Amgen, Inc. (AMGN) Raised by Jefferies Financial Group
www.americanbankingnews.com - July 10 at 6:38 AM
Why Amgen is a Top 25 Dividend Giant (AMGN)Why Amgen is a Top 25 Dividend Giant (AMGN)
www.nasdaq.com - July 9 at 5:05 PM
Bullish Options Bias in Amgen (AMGN) Ahead of July 26th Earnings Announcement, Targets Upside in Shares Above $200/Sh -SusquehannaBullish Options Bias in Amgen (AMGN) Ahead of July 26th Earnings Announcement, Targets Upside in Shares Above $200/Sh -Susquehanna
www.streetinsider.com - July 9 at 5:05 PM
Amgen, Inc. (AMGN) Receives Average Recommendation of "Hold" from BrokeragesAmgen, Inc. (AMGN) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - July 7 at 2:36 AM
Amgen, Inc. (AMGN) Expected to Announce Quarterly Sales of $5.75 BillionAmgen, Inc. (AMGN) Expected to Announce Quarterly Sales of $5.75 Billion
www.americanbankingnews.com - July 5 at 1:06 AM
Amgen, Inc. (AMGN) Expected to Announce Earnings of $3.52 Per ShareAmgen, Inc. (AMGN) Expected to Announce Earnings of $3.52 Per Share
www.americanbankingnews.com - July 4 at 12:10 AM
Amgen sues Durham generics companyAmgen sues Durham generics company
finance.yahoo.com - July 3 at 5:19 PM
Should Value Investors Consider Amgen (AMGN) Stock Now?Should Value Investors Consider Amgen (AMGN) Stock Now?
finance.yahoo.com - July 2 at 4:59 PM
4 Drug and Biotech Stocks Awaiting FDA Decisions in July4 Drug and Biotech Stocks Awaiting FDA Decisions in July
www.zacks.com - July 2 at 8:00 AM
Better Buy: Amgen Inc. vs. Pfizer Inc.Better Buy: Amgen Inc. vs. Pfizer Inc.
finance.yahoo.com - July 1 at 8:03 AM
Amgen And Novartis Present New Data Demonstrating Long-Term Efficacy, Safety And Tolerability Of Aimovig™ (erenumab-aooe) In Patients With Chronic And Episodic MigraineAmgen And Novartis Present New Data Demonstrating Long-Term Efficacy, Safety And Tolerability Of Aimovig™ (erenumab-aooe) In Patients With Chronic And Episodic Migraine
finance.yahoo.com - June 28 at 5:56 PM
Rhode Island considers tax credits for biotech companyRhode Island considers tax credits for biotech company
marketbeat.com - June 28 at 12:37 PM
Amgen Announced the Phase 3 Results for ABP 710Amgen Announced the Phase 3 Results for ABP 710
finance.yahoo.com - June 28 at 8:53 AM
Amgen Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Candidate To InfliximabAmgen Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Candidate To Infliximab
www.bizjournals.com - June 27 at 5:58 PM
Has Amgen (AMGN) Outpaced Other Medical Stocks This Year?Has Amgen (AMGN) Outpaced Other Medical Stocks This Year?
www.zacks.com - June 27 at 5:58 PM
Amgen says infliximab biosimilar candidate data confirm non-inferiorityAmgen says infliximab biosimilar candidate data confirm non-inferiority
seekingalpha.com - June 27 at 5:58 PM
Amgen And Health And Benefits Consultant Piper Jordan Partner On First Migraine Project With EmployersAmgen And Health And Benefits Consultant Piper Jordan Partner On First Migraine Project With Employers
finance.yahoo.com - June 27 at 5:58 PM
Amgen And Novartis Highlight Findings From A Large Global Patient Survey Revealing That Worldwide Approximately 60 Percent Of Employed People With Migraine Missed, On Average, A Week Of Work In A MonthAmgen And Novartis Highlight Findings From A Large Global Patient Survey Revealing That Worldwide Approximately 60 Percent Of Employed People With Migraine Missed, On Average, A Week Of Work In A Month
finance.yahoo.com - June 27 at 5:58 PM
5 Biotech Stocks That Could Be the Next Amgen5 Biotech Stocks That Could Be the Next Amgen
investorplace.com - June 27 at 11:03 AM
Apple Led Company Stock Buybacks During Q1Apple Led Company Stock Buybacks During Q1
finance.yahoo.com - June 26 at 8:37 AM
Analyzing Amgen (AMGN) and aTyr Pharma (LIFE)Analyzing Amgen (AMGN) and aTyr Pharma (LIFE)
www.americanbankingnews.com - June 25 at 9:26 PM
Amgen's Repatha Reduces Bad Cholestrol in Type II DiabetesAmgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
finance.yahoo.com - June 25 at 5:44 PM
Amgens Repatha Reduces Bad Cholestrol in Type II DiabetesAmgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
www.zacks.com - June 25 at 10:10 AM
Cambridge biotech startup grabs $65M to tackle liver diseaseCambridge biotech startup grabs $65M to tackle liver disease
finance.yahoo.com - June 25 at 10:10 AM
See what the IHS Markit Score report has to say about Amgen Inc.See what the IHS Markit Score report has to say about Amgen Inc.
finance.yahoo.com - June 25 at 10:10 AM
Long-Term Investors Take Note -- These 5 Big Pharma Companies Have the Best PipelinesLong-Term Investors Take Note -- These 5 Big Pharma Companies Have the Best Pipelines
finance.yahoo.com - June 24 at 8:00 AM
Data Presented at the 78th Scientific Sessions of the American Diabetes AssociationData Presented at the 78th Scientific Sessions of the American Diabetes Association
www.streetinsider.com - June 23 at 7:13 PM
Amgen: Repatha Significantly Reduces LDL-C, Non-HDL-C In High-risk PatientsAmgen: Repatha Significantly Reduces LDL-C, Non-HDL-C In High-risk Patients
www.nasdaq.com - June 23 at 7:13 PM
This page was last updated on 7/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.